Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjects.
The mechanisms that lead from obesity to atherosclerotic disease are not fully understood. Obesity involves angiogenesis in which vascular endothelial growth factor-A (VEGF-A) plays a key role. On the other hand, vascular endothelial growth factor-C (VEGF-C) plays a pivotal role in lymphangiogenesis. Circulating levels of VEGF-A and VEGF-C are elevated in sera from obese subjects. However, relationships of VEGF-C with atherosclerotic risk factors and atherosclerosis are unknown. We determined circulating levels of VEGF-A and VEGF-C in 423 consecutive subjects not receiving any drugs at the Health Evaluation Center. After adjusting for age and gender, VEGF-A levels were significantly and more strongly correlated with the body mass index (BMI) and waist circumference than VEGF-C. Conversely, VEGF-C levels were significantly and more closely correlated with metabolic (e.g., fasting plasma glucose, hemoglobin A1c, immunoreactive insulin, and the homeostasis model assessment of insulin resistance) and lipid parameters (e.g., triglycerides, total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-C), and non-high-density-lipoprotein cholesterol (non-HDL-C)) than VEGF-A. Stepwise regression analyses revealed that independent determinants of VEGF-A were the BMI and age, whereas strong independent determinants of VEGF-C were age, triglycerides, and non-HDL-C. In apolipoprotein E-deficient mice fed a high-fat-diet (HFD) or normal chow (NC) for 16 weeks, levels of VEGF-A were not significantly different between the two groups. However, levels of VEGF-C were significantly higher in HFD mice with advanced atherosclerosis and marked hypercholesterolemia than NC mice. Furthermore, immunohistochemistry revealed that the expression of VEGF-C in atheromatous plaque of the aortic sinus was significantly intensified by feeding HFD compared to NC, while that of VEGF-A was not. In conclusion, these findings demonstrate that VEGF-C, rather than VEGF-A, is closely related to dyslipidemia and atherosclerosis.
Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto, Japan. hwada@kuhp.kyoto-u.ac.jp
Hiromichi
H
Wada
Shuichi
S
Ura
Shuji
S
Kitaoka
Noriko
N
Satoh-Asahara
Takahiro
T
Horie
Koh
K
Ono
Tomohide
T
Takaya
Rieko
R
Takanabe-Mori
Masaharu
M
Akao
Mitsuru
M
Abe
Tatsuya
T
Morimoto
Toshinori
T
Murayama
Masayuki
M
Yokode
Masatoshi
M
Fujita
Akira
A
Shimatsu
Koji
K
Hasegawa
D000818:Animals; D001057:Apolipoproteins E / Q000172:deficiency; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D051379:Mice; D008875:Middle Aged; D058226:Plaque, Atherosclerotic / Q000097:blood / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*; D042582:Vascular Endothelial Growth Factor C / Q000097:blood*
D001057:Apolipoproteins E; D042461:Vascular Endothelial Growth Factor A; D042582:Vascular Endothelial Growth Factor C